Cargando…
The interactions of novel mononuclear platinum-based complexes with DNA
BACKGROUND: Cisplatin has been widely used for the treatment of cancer and its antitumour activity is attributed to its capacity to form DNA adducts, predominantly at guanine residues, which impede cellular processes such as DNA replication and transcription. However, there are associated toxicity a...
Autores principales: | Johnson, Ben W., Burgess, Mark W., Murray, Vincent, Aldrich-Wright, Janice R., Temple, Mark D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6303901/ https://www.ncbi.nlm.nih.gov/pubmed/30577821 http://dx.doi.org/10.1186/s12885-018-5194-8 |
Ejemplares similares
-
Characterisation of the DNA sequence specificity, cellular toxicity and cross-linking properties of novel bispyridine-based dinuclear platinum complexes
por: Johnson, Ben W., et al.
Publicado: (2016) -
Bioactive Platinum(IV) Complexes Incorporating Halogenated Phenylacetates
por: Aputen, Angelico D., et al.
Publicado: (2022) -
Induction of a Four‐Way Junction Structure in the DNA Palindromic Hexanucleotide 5′‐d(CGTACG)‐3′ by a Mononuclear Platinum Complex
por: van Rixel, Vincent H. S., et al.
Publicado: (2019) -
Potent Chlorambucil-Platinum(IV) Prodrugs
por: Aputen, Angelico D., et al.
Publicado: (2022) -
Solvent‐Dependent Reactivity and Photochemistry of Dinuclear and Mononuclear Platinum(IV) Azido Triazaolato Complexes
por: Yao, Kezi, et al.
Publicado: (2021)